tiprankstipranks
Trending News
More News >
Humacyte (HUMA)
NASDAQ:HUMA
US Market

Humacyte (HUMA) Financial Statements

Compare
1,539 Followers

Humacyte Financial Overview

Humacyte's market cap is currently $212.30M. The company's EPS TTM is $-0.11; its P/E ratio is -4.65; Humacyte is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 1.56M$ 1.26M$ 1.49M
Gross Profit$ -7.19M$ -76.55M$ -6.69M$ -60.08M$ -52.59M
Operating Income$ -114.40M$ -100.05M$ -84.58M$ -81.21M$ -64.60M
EBITDA$ -132.23M$ -96.46M$ -76.37M$ -72.97M$ -56.25M
Net Income$ -148.70M$ -110.78M$ -11.96M$ -26.48M$ -66.52M
Balance Sheet
Cash & Short-Term Investments$ 44.94M$ 80.45M$ 151.88M$ 225.50M$ 39.93M
Total Assets$ 137.87M$ 128.22M$ 204.30M$ 286.53M$ 106.69M
Total Debt$ 16.54M$ 57.45M$ 50.07M$ 51.18M$ 28.86M
Net Debt$ -28.40M$ -23.00M$ -99.71M$ -166.32M$ -11.07M
Total Liabilities$ 190.54M$ 114.68M$ 87.37M$ 164.36M$ 36.02M
Stockholders' Equity$ -52.67M$ 13.55M$ 116.93M$ 122.17M$ 70.67M
Cash Flow
Free Cash Flow$ -99.69M$ -75.58M$ -72.18M$ -81.41M$ -55.89M
Operating Cash Flow$ -98.12M$ -73.31M$ -71.13M$ -81.19M$ -55.57M
Investing Cash Flow$ -1.57M$ -173.00K$ 4.84M$ -8.22M$ -268.00K
Financing Cash Flow$ 114.18M$ 4.51M$ -1.45M$ 266.98M$ 2.05M
Currency in USD

Humacyte Earnings and Revenue History

Humacyte Debt to Assets

Humacyte Cash Flow

Humacyte Forecast EPS vs Actual EPS